is an annual event sponsored by the University of Lausanne and the Conférence Universitaire de Suisse Occidentale (CUSO). This 2-day event will bring to Lausanne investigators from Europe and the United States to present and discuss the newest developments in genomics and genomic technologies and their impact on biological research.
Thursday & Friday February 7 & 8, 2019
Génopode, Aud. C
Thursday February 7, 2019
09:00 Anja Spang (Royal Netherlands Institute for Sea Research, Texel, Netherlands)
Archaea – Their expanding diversity and role in key evolutionary events
09:45 Richard Neher (Biozentrum, Basel, Switzerland)
Tracking infectious disease and drug resistance using whole genome sequencing
10:30 Coffee Break
11:00 Laura Florez (Johannes Gutenberg-Universität, Mainz, Germany)
Genomic clues to chemical defense in bacterial symbionts of a beetle
11:45 Malik Harmit (Fred Hutchinson Cancer Research Center, Seattle, USA)
Genetic conflicts during meiosis shape centromeres and species
12:30 LUNCH (sandwiches and drinks provided in Exhibition Hall)
14:00 Marc Robinson-Rechavi (DEE, University of Lausanne, Lausanne, Switzerland)
Duplication, cause or consequence of gene function?
14:45 Catherine Peichel (University of Bern, Bern, Switzerland)
Genomics of adaptation and speciation in sticklebacks
15:30 Apéro
Friday February 8, 2019
09:00 Youssef Belkhadir (Gregor Mendel Institute of Molecular Plant Biology, Vienna, Austria)
Molecular logic in large-scale receptor-receptor interaction networks
09:45 Ute Kraemer (Ruhr-Universität, Bochum, Germany)
Plant adaptation to local soil composition
10:30 Coffee Break
11:00 Stefan Ameres (Institute of Molecular Biotechnology, Vienna, Austria)
Time resolved RNA sequencing provides insights into the molecular basis of gene regulation
11:45 Elvire Gouze (Institut de Biologie Valrose, Nice, France)
Development of a biotherapy for achondroplasia
12:30 LUNCH (sandwiches and drinks provided in Exhibition Hall)
14:00 Anita Rauch (University of Zurich, Zurich, Switzerland)
Tracing the missing heritability in neurodevelopmental disorders
14:45 Quitterie Venot (Institut Necker Enfants Malades, Paris, France)
Molecular targeted therapy in PIK3CA related overgrowth syndrome (PROS)